To compare the efficacy of lasers of two different wavelengths (810 nm and 577 nm) for the treatment of central serous chorioretinopathy.
Not Applicable
- Conditions
- Health Condition 1: H357- Separation of retinal layers
- Registration Number
- CTRI/2020/10/028374
- Lead Sponsor
- Armed Forces Medical Research Cell
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
(i)Vision loss for a duration of minimum 3 months due to persistent CSC
(ii)Focal leaks (upto two leaks) on fundus fluorescein angiography (FFA).
Exclusion Criteria
(1) chronic CSCR characterized by RPE atrophy, diffuse leak on FFA; (2) history of treatment for CSCR in the past; (3) multiple leaks on FFA; (4) any other vitreoretinal disorder currently or in the past; (5) any intraocular procedure in the past 6 months; (6) systemic or topical steroid therapy currently/ in the past 6 months; (7) presence of opaque media likely to affect quality of imaging; (8) spherical equivalent ⩾± 6D.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Resolution of subretinal fluid.Timepoint: 1 month, 3 months and 6 months after treatment.
- Secondary Outcome Measures
Name Time Method (i)To compare the functional outcome of the treatment assessed by best corrected visual acuity (BCVA). <br/ ><br>(ii)To report any ocular adverse effect in either treatment arm. <br/ ><br>Timepoint: 1,2,3, and 6 months